Category Archives: Press

NEW YORK, NY - April 3, 2012 - The Spinal Muscular Atrophy (SMA) Foundation announced today the launch of a biomarker assay panel for SMA using Myriad...

Milestone Demonstrates Effectiveness of RBM's Strategic Biomarker Services AUSTIN, Texas, May 25, 2011 /PRNewswire/ -- Rules-Based Medicine (RBM),...

Expansion of IP portfolio to support development and commercialization of novel tests for neurodegenerative diseases AUSTIN, Texas, May 17, 2011 /P...

RBM's TruCulture® sample collection system will be an integral part of study AUSTIN, Texas, May 12, 2011 /PRNewswire/ -- Rules-Based Medicine, Inc....

Acquisition Expands Myriad's Leadership Position in Companion Diagnostics SALT LAKE CITY and AUSTIN, Texas, April 27, 2011 (GLOBE NEWSWIRE) -- Myri...

Panel of 101 quantitative biomarker tests selected in partnership with the National Cancer Institute AUSTIN, Texas, March 24, 2011 /PRNewswire/ --...

NEW YORK, NY AND AUSTIN, TX - January, 2011 - The Spinal Muscular Atrophy (SMA) Foundation and Rules-Based Medicine, Inc. (RBM) announced today that t...